Prenatal Ultrasonographic Features Associated With ARSL and X-Linked Chondrodysplasia Punctata 1 (CDPX1): Literature Review and Case Series
- PMID: 39313411
- DOI: 10.1002/pd.6649
Prenatal Ultrasonographic Features Associated With ARSL and X-Linked Chondrodysplasia Punctata 1 (CDPX1): Literature Review and Case Series
Abstract
Background: Chondrodysplasia punctata 1 (CDPX1) is an X-linked recessive disorder of cartilage and bone development characterized by stippling on the cartilage and bone, flattened nasal bridge, and brachydactyly, or short fingers. CDPX1 has been associated with variants in the ARSL gene and is known to manifest prenatally, however, there has been no systematic literature review on this evidence.
Aims: Here, we reviewed the current literature on prenatal manifestations of CDPX1, and additionally introduce previously unpublished cases.
Materials & methods: A systematic review of the literature was performed. Additionally, a GeneMatcher submission was created and a call for cases was presented at the Fetal Sequencing Consortium meetings to find previously unpublished cases.
Results: For the 22 fetuses reported here, we found that 55% had nasal hypoplasia, 41% had bony stippling or calcifications, 32% had polyhydramnios, 5% had oligohydramnios, 23% had shortened long bones, 23% had spinal canal stenosis, 18% had ventriculomegaly, 9% had brachydactyly/brachytelephalangy, 9% had clubbed feet, 9% had premature rupture of membranes, and 9% had intraventricular hemorrhage detected through sonography or radiography. We also found 17 unique variants in ARSL for these 22 fetuses.
Discussion: A previously unpublished association of ARSL variants with intrauterine fetal death or stillbirth has been noted in this study. It is also possible that intracranial hemorrhage is an underrecognized feature associated with CDPX1 variation. However, there have been challenges in applying ACMG criteria to ARSL, a gene without an associated Variant Curation Expert Panel.
Conclusion: This literature review and case series highlights which features of CDPX1 manifest prenatally, as well as introduces new phenotypes that have not been previously identified.
© 2024 John Wiley & Sons Ltd.
References
-
- Clinical Genome Resource, https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_2c48d8....
-
- B. Franco, G. Meroni, G. Parenti, et al., “A Cluster of Sulfatase Genes on Xp22.3: Mutations in Chondrodysplasia Punctata (CDPX) and Implications for Warfarin Embryopathy,” Cell 81, no. 1 (April 1995): 15–25, https://doi.org/10.1016/0092-8674(95)90367-4.
-
- J. L. Giordano and R. J. Wapner, “The Fetal Sequencing Consortium: The Value of Multidisciplinary Dialog and Collaboration,” Prenatal Diagnosis 42, no. 7 (June 2022): 807–810, https://doi.org/10.1002/pd.6190.
-
- N. Brunetti‐Pierri, M. V. Andreucci, R. Tuzzi, et al., “X‐Linked Recessive Chondrodysplasia Punctata: Spectrum of Arylsulfatase E Gene Mutations and Expanded Clinical Variability,” American Journal of Medical Genetics, Part A 117A, no. 2 (March 2003): 164–168, https://doi.org/10.1002/ajmg.a.10950.
-
- A. Garnier, S. Dauger, D. Eurin, et al., “Brachytelephalangic Chondrodysplasia Punctata With Severe Spinal Cord Compression: Report of Four New Cases,” European Journal of Pediatrics 166, no. 4 (April 2007): 327–331, https://doi.org/10.1007/s00431-006-0239-4.
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
- APP1123341/National Health and Medical Research Council
- KL2TR002552/National Institutes of Health's National Center for Advancing Translational Science
- GHFM76777/Genomics Health Futures Mission-Medical Research Futures Fund
- GNT1113531/Australian Genomic Health Alliance NHMRC Targeted Call for Research into Preparing Australia for the Genomics Revolution in Healthcare
LinkOut - more resources
Full Text Sources
Miscellaneous
